South-East Asia (WHO region) vs Zimbabwe: New cases tested for RR-/MDR-TB
South-East Asia (WHO region)
91.0%
in 2024
Zimbabwe
100.0%
in 2024
South-East Asia (WHO region) rank
1st
Zimbabwe rank
1st
New cases tested for RR-/MDR-TB over time
- South-East Asia (WHO region)
- Zimbabwe
How they compare
Zimbabwe currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Zimbabwe's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 3 times across 10 shared years of data; in 2011 it was South-East Asia (WHO region) ahead.
South-East Asia (WHO region) ranks 1st and Zimbabwe ranks 1st of 11 groups.
Zimbabwe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.3% | 45.2% | 23.9% | Zimbabwe |
| 2020s | 80.2% | 97.5% | 17.2% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, South-East Asia (WHO region) or Zimbabwe?
- Zimbabwe, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between South-East Asia (WHO region) and Zimbabwe?
- 9.0%, with Zimbabwe ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Zimbabwe?
- 10 years are reported by both, from 2011 to 2024.
- How do South-East Asia (WHO region) and Zimbabwe rank globally for new cases tested for rr-/mdr-tb?
- South-East Asia (WHO region) ranks 1st and Zimbabwe ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.